Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAFV600E/p38α kinase inhibitory activity: Synthesis, in vitro assays and in silico study

Eslam M.H. Ali, Karim I. Mersal, Usama M. Ammar, Seyed Omar Zaraei, Mohammed S. Abdel-Maksoud, Mohammed I. El-Gamal, Md Mamunul Haque, Tanuza Das, Eunice Eun Kyeong Kim, Jun Seok Lee, Kwan Hyi Lee, Hee Kwon Kim, Chang Hyun Oh

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAFV600E/p38α kinase inhibitory activity: Synthesis, in vitro assays and in silico study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds